<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02536729</url>
  </required_header>
  <id_info>
    <org_study_id>TRAVAD2015</org_study_id>
    <nct_id>NCT02536729</nct_id>
  </id_info>
  <brief_title>Evaluation of the Quality of Life of Patients Requiring Intestinal Cleansing Using Oral Medications to Imaging Procedure by Patient Reported Outcome</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Salutia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tecnoquimicas S.A</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundación Salutia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: The primary objective of this study is to assess the quality of life of people
      treated with oral phosphate compared with polyethylene glycol + electrolytes to imaging
      procedures, according to the outcome variables reported by patients.

      Type of study: A non-interventional observational analytic prospective cohort study.

      Sample: We will include people who need bowel cleansing for the realization of imaging tests

      Exposures: - oral sodium phosphate normal regimen

        -  Oral sodium phosphate with modified diet

        -  Polyethylene Glycol + electrolytes

      Follow-up time: 8 days after the bowel preparation

      Outcomes: Boston Scale measure Safety Differences between groups in blood test (Sodium,
      Potassium, Calcium)
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2015</start_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Boston scale for bowel cleansing</measure>
    <time_frame>2 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of adverse events</measure>
    <time_frame>8 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>8 days</time_frame>
    <description>Quality of life measured with EQ5D-3L scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood creatinine</measure>
    <time_frame>8 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood urea nitrogen (BUN)</measure>
    <time_frame>8 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Sodium</measure>
    <time_frame>8 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Potassium</measure>
    <time_frame>8 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Calcium</measure>
    <time_frame>8 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Phosphorus</measure>
    <time_frame>8 days</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Bowel Preparation</condition>
  <arm_group>
    <arm_group_label>Oral Sodium Phosphate - Normal preparation</arm_group_label>
    <description>Oral sodium phospate exposure with special diet (Liquid)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral Sodium Phosphate - Modified preparation</arm_group_label>
    <description>Oral sodium phospate exposure with special diet (Liquid), but the participant can normally lunch the day before the test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>polyethylene glycol + Electrolytes</arm_group_label>
    <description>polyethylene glycol + Electrolytes exosure with special diet (Liquid)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral Sodium Phosphate - Normal preparation</intervention_name>
    <arm_group_label>Oral Sodium Phosphate - Normal preparation</arm_group_label>
    <other_name>Travad</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral sodium phosphate - Modified Preparation</intervention_name>
    <arm_group_label>Oral Sodium Phosphate - Modified preparation</arm_group_label>
    <other_name>Travad</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>polyethylene glycol + Electrolytes</intervention_name>
    <arm_group_label>polyethylene glycol + Electrolytes</arm_group_label>
    <other_name>PEG</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults who are in diagnostic centers, which have order for an imaging procedure that
        requires intestinal cleansing conducted.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients which have order for an imaging procedure that requires bowel cleansing

          -  Older than 18 years and younger than 65 years old

          -  Accept to participate in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 27, 2015</study_first_submitted>
  <study_first_submitted_qc>August 31, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2015</study_first_posted>
  <last_update_submitted>August 31, 2015</last_update_submitted>
  <last_update_submitted_qc>August 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

